AzTrials
AzTrials

Chronic Low Back PainNRM_2009NCT02487368

Effects of a Mechanical Needle Stimulation Pad on Chronic Low Back Pain

A study testing Needle stimulation pad in people with Chronic Low Back Pain and Recurrent Low Back Pain, run by Universität Duisburg-Essen.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The needle stimulation pad is a self-care device, which has been promoted for pain control and well-being. The aim of the study was to test the efficacy of the pad for chronic/recurrent low back pain treatment. Read more about this study

Who is it for?
Ages 18 to 75 years
What is being tested?
Needle stimulation pad
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
166 participants
Where
No sites listed yet
Study dates
Oct 2009to Dec 2010
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • chronic or recurrent low back pain in the past 12 months
  • average pain intensity 4 out of 10 points

Who cannot join

  • malignant back pain
  • congenital deformities of the spine
  • dystonia or other movement disorders
  • spinal surgery within 12 months prior
  • pregnancy
  • dermatological diseases in the areas treated
Show all 9Show fewer
  • tendency for hemorrhages
  • severe mental illness
  • recent treatment with anticoagulation, corticoid medication, acupuncture

About this study

The needle stimulation pad is a self-care device, which has been promoted for pain control and well-being. The aim of the study was to test the efficacy of the pad for chronic/recurrent low back pain treatment.

Patients with non-specific chronic or recurrent low back pain were selected from a large health insurance company database and advised to use the pad daily for two weeks; outcomes were assessed at baseline, weeks 2 and 14. Primary outcome measure was pain intensity at week 2; secondary outcome measures included the Oswestry disability index (ODI), health-related quality of life (SF-36), the fear avoidance beliefs questionnaire (FABQ), analgesic medication consumption and safety.

Read the detailed description

see above

Being tested
Needle stimulation pad
Medical subject headings
Low Back Pain

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Needle stimulation padDevice

    Also called Shakti mat, Bed of nails

Study groups in NCT02487368
Study groupRoleWhat they receive
Needle stimulation padExperimentala self-administered treatment with a mechanical needle stimulation pad, a mechanical device to be used for 30 minutes daily for 14 days.
Receives: Device: Needle stimulation pad

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Pain intensity

    Visual analogue scale

    Measured: day 14

Secondary outcomes (11)
  1. Pain intensity

    Visual analogue scale

    Measured: Week 14

  2. Oswestry Low Back Pain Disability Index

    Measured: Day 14

  3. Oswestry Low Back Pain Disability Index

    Measured: Week 14

  4. Short Form 36 Health Survey Questionnaire (SF-36)

    Measured: Day 14

  5. Short Form 36 Health Survey Questionnaire (SF-36)

    Measured: Week 14

  6. Fear Avoidance Beliefs Questionnaire (FABQ)

    Measured: Day 14

  7. Fear Avoidance Beliefs Questionnaire (FABQ)

    Measured: Week 14

  8. Experiences with the intervention

    Open question: "please indicate observed changes"

    Measured: Day 14

  9. Medication use

    Use of medication, daily log

    Measured: Day 14

  10. Number of any adverse events

    Measured: Day 14

  11. Pain intensity measured immediately after the application, visual analogue scale

    Measured: 5 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted1 Jul 2015 (estimated)
  2. Study startOct 2009
  3. Primary completionDec 2010
  4. Study completionDec 2010

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
166 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02487368
Sponsor's protocol ID
NRM_2009
Acronym
NRM_2009
Status last verified
Jul 2015
First submitted
29 Jun 2015
Last updated
2 Jul 2015
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing Needle stimulation pad in people with Chronic Low Back Pain and Recurrent Low Back Pain, run by Universität Duisburg-Essen.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 Jul 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Pain intensity (time frame: day 14). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Jul 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in